| Bid Price | 9.00p | High Price | 9.50p |
|---|
| Ask Price | 9.50p | Low Price | 9.03p |
|---|
| Open Price | 9.50p | Spread | 5.26% |
|---|
| Prev Close | 9.50p | Volume | 26,102 |
|---|
Renalytix PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Sep 20, 2024 | 9.50 | 9.50 | 9.03 | 9.25 | 26,102 |
| Sep 19, 2024 | 9.50 | 10.00 | 9.50 | 9.50 | 84,969 |
| Sep 18, 2024 | 9.50 | 9.65 | 9.65 | 9.50 | 3,250 |
| Sep 17, 2024 | 9.50 | 10.00 | 9.10 | 9.50 | 38,278 |
| Sep 16, 2024 | 9.50 | 9.75 | 9.26 | 9.50 | 16,511 |
Renalytix PLC Information
| Name | Renalytix PLC | Index | FTSE AIM All Share |
|---|
| ISIN | GB00BYWL4Y04 | Epic | RENX |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | ASX1 |
|---|
| Industry | Health Information Services | Sector | Healthcare |
|---|
| EMS | 2,000 | Trading Status | Closed |
|---|
| Shares in Issue | 165.93 m | Prev Close | 9.50p |
|---|
| PE Ratio | | Market Cap | £15.35 m |
|---|
| Div Yield | 0 | Div per Share | $NaN |
|---|
| EPS | -$0.27 | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | n/a | DPS Growth (%) | 0 |
|---|
| Current Ratio | 0.423005 | Quick Ratio | 0.350814 |
|---|
Renalytix PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 18/03/24 | PLAC | Christopher Mills | NED | 4,000,000 @ £0.20 | £800,000.00 |
| 10/02/23 | PLAC | Christopher Mills | NED | 346,375 @ £0.90 | £311,738.00 |
| 07/04/22 | PLAC | Ann Berman | RES | 27,586 @ $2.76 | $76,137.00 |
| 07/04/22 | PLAC | Timothy Scannell | RES | 68,964 @ £2.76 | £190,341.00 |
| 07/04/22 | PLAC | Christopher Mills | NED | 551,724 @ £2.76 | £1,522,758.00 |
| 17/12/21 | BUY | Ann Berman | RES | 6,000 @ $7.00 | $42,000.00 |
| 13/12/21 | BUY | James McCullough | CEO | 2,370 @ $7.90 | $18,711.00 |
| 09/12/21 | BUY | Ann Berman | RES | 6,000 @ $7.50 | $45,000.00 |
| 09/12/21 | BUY | James McCullough | CEO | 66 @ $7.50 | $495.00 |
| 09/12/21 | BUY | James McCullough | CEO | 1,000 @ $7.80 | $7,800.00 |
Renalytix PLC News
